Literature DB >> 22618469

Individualization of a pharmacokinetic model by fractional and nonlinear fit improvement.

Jovan K Popović1, Mihalj Poša, Kosta J Popović, Dušica J Popović, Nataša Milošević, Vesna Tepavčević.   

Abstract

This study presents application of a new linear and nonlinear fractional derivative two compartmental model to the evaluation of individual pharmacokinetics. In the model, the integer order derivatives are replaced by derivatives of real order. A specific nonlinear function is used for the fit improvement of a fractional derivative two compartmental model with the mass balance conservation. The agreement of the values predicted by the proposed model with the values obtained through experiments with bumetanide tablets in human volunteers is shown to be good. Thus, pharmacokinetics of bumetanide can be described well by a linear or a nonlinear two compartmental model with fractional derivatives of the same order proposed here. Parameters in the model are determined by the least squares method and the particle swarm optimization numerical procedure is used. The results show that the linear fractional order two compartmental model for bumetanide is useful improvement of the classical (integer order) two compartmental model and that the nonlinear fractional order model is useful improvement of the linear model in a great number of volunteers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22618469     DOI: 10.1007/s13318-012-0097-6

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  23 in total

1.  Power law IVIVC: an application of fractional kinetics for drug release and absorption.

Authors:  John Kytariolos; Aristides Dokoumetzidis; Panos Macheras
Journal:  Eur J Pharm Sci       Date:  2010-07-03       Impact factor: 4.384

2.  Fractional kinetics in multi-compartmental systems.

Authors:  Aristides Dokoumetzidis; Richard Magin; Panos Macheras
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-10-01       Impact factor: 2.745

3.  Bumetanide: radioimmunoassay and pharmacokinetic profile in humans.

Authors:  W R Dixon; R L Young; A Holazo; M L Jack; R E Weinfeld; K Alexander; A Liebman; S A Kaplan
Journal:  J Pharm Sci       Date:  1976-05       Impact factor: 3.534

4.  The pharmacokinetics and pharmacodynamics of bumetanide in normal subjects.

Authors:  L A Marcantonio; W H Auld; G G Skellern; C A Howes; W R Murdoch; R Purohit
Journal:  J Pharmacokinet Biopharm       Date:  1982-08

5.  Simulation of Drug Uptake in a Two Compartmental Fractional Model for a Biological System.

Authors:  Ivo Petráš; Richard L Magin
Journal:  Commun Nonlinear Sci Numer Simul       Date:  2011-12       Impact factor: 4.260

6.  Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC).

Authors:  Sandeep Dutta; Yihong Qiu; Emil Samara; Guoliang Cao; G Richard Granneman
Journal:  J Pharm Sci       Date:  2005-09       Impact factor: 3.534

7.  Fractional compartmental models and multi-term Mittag-Leffler response functions.

Authors:  Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-04-20       Impact factor: 2.745

8.  Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with congestive heart failure.

Authors:  J A Cook; D E Smith; L A Cornish; R M Tankanow; J M Nicklas; M L Hyneck
Journal:  Clin Pharmacol Ther       Date:  1988-11       Impact factor: 6.875

9.  The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease.

Authors:  L A Marcantonio; W H Auld; W R Murdoch; R Purohit; G G Skellern; C A Howes
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

10.  Bumetanide kinetics in renal failure.

Authors:  P J Pentikäinen; A Pasternack; E Lampainen; P J Neuvonen; A Penttilä
Journal:  Clin Pharmacol Ther       Date:  1985-05       Impact factor: 6.875

View more
  2 in total

1.  How to avoid unbounded drug accumulation with fractional pharmacokinetics.

Authors:  Maud Hennion; Emmanuel Hanert
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-12       Impact factor: 2.745

2.  Fractional calculus in pharmacokinetics.

Authors:  Pantelis Sopasakis; Haralambos Sarimveis; Panos Macheras; Aristides Dokoumetzidis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-10-03       Impact factor: 2.745

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.